Clinical Trials Using Anti-IL-13 Humanized Monoclonal Antibody TNX-650
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-IL-13 Humanized Monoclonal Antibody TNX-650. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
The purpose of this study is to determine the safety and effectiveness of TNX-650 for Injection when administered to patients with refractory Hodgkin's lymphoma.
Location: See Clinical Trials.gov